GlaxoSmithKline Pakistan Limited
PPSX:GLAXO310.22
PKR
-3.30
(-1.05%)
GlaxoSmithKline Pakistan Limited
PSX:GLAXO
(Pakistan Stock Exchange)
Recent
price
310.22
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- GlaxoSmithKline Pakistan Limited operates as a research-based biopharmaceutical company engaged in the manufacturing, marketing, distribution, and sale of prescription medicines, specialty pharmaceuticals, and vaccines. The company operates through two core business segments: Pharmaceuticals and Vaccines. Its pharmaceutical portfolio encompasses therapeutic categories including anti-infectives and antibiotics, such as Augmentin, Amoxil, Velosef, and Zinnat; respiratory and allergy medications, such as Ventolin, Seretide, Flixotide, and Avamys; dermatology treatments, including Betnovate, Dermovate, and Cutivate; central nervous system and pain management formulations, including Lamictal, Wellbutrin, and Imigran; and cardiovascular and metabolic therapies, such as Tenormin, Lanoxin, and Zyloric. In its vaccines business, the company supplies immunizations against pediatric and adult infectious diseases, including Rotarix for rotavirus, Synflorix for pneumococcal disease, Infanrix for diphtheria, tetanus, and pertussis, Havrix and Engerix-B for hepatitis, Priorix for measles, mumps, and rubella, and Cervarix for human papillomavirus, alongside expanding access to specialized adult vaccines like Shingrix. The company distributes its products to retail pharmacies, private clinics, healthcare institutions, government agencies, and tertiary care hospitals across Pakistan, with manufacturing facilities situated in Karachi. GlaxoSmithKline Pakistan Limited operates as a subsidiary of Glaxo Group Limited, under ultimate parent GSK plc. In recent developments, the company completed the strategic carve-out and demerger of its consumer healthcare business following the global spin-off of Haleon plc, transitioning GSK Pakistan into a pure-play prescription biopharmaceutical and vaccines enterprise. To address local macroeconomic headwinds and currency volatility, the company has undertaken operational restructuring, local manufacturing efficiency upgrades, selective portfolio rationalization of non-core legacy mature brands, and targeted supply chain localization initiatives while expanding the introduction of innovative specialty medicines and public health immunization programs. Founded in 1948, GlaxoSmithKline Pakistan Limited is headquartered in Karachi, Pakistan.